Aethlon Medical Inc AEMD

NAS: AEMD | ISIN: US00808Y3071   30/04/2025
0,381 USD (-6,41%)
(-6,41%)   30/04/2025

10 maart 2025 · Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal · Persbericht

27 augustus 2024 · Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenated Rewarming of Discarded Donor Kidneys · Persbericht

14 augustus 2024 · Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2024 and Provides Corporate Update · Persbericht

12 augustus 2024 · Aethlon Medical Receives Second Ethics Committee Approval for Hemopurifier® Cancer Trial · Persbericht

6 augustus 2024 · Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 14, 2024 · Persbericht

27 juni 2024 · Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update · Persbericht

21 juni 2024 · Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27, 2024 · Persbericht

18 juni 2024 · Aethlon Medical Receives Ethics Committee Approval for Hemopurifier® Cancer Trial · Persbericht

3 juni 2024 · Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies · Persbericht

15 mei 2024 · Aethlon Medical Announces Pricing of $4.7 Million Public Offering · Persbericht

10 mei 2024 · Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma · Persbericht

21 februari 2024 · Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices · Persbericht

14 februari 2024 · Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update · Persbericht

7 februari 2024 · Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024 · Persbericht

6 november 2023 · Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023 · Persbericht

10 oktober 2023 · Aethlon Receives Clearance From Drug Controller General of India For Potential Phase 1 Trial of its Hemopurifier® in Oncology · Persbericht

4 oktober 2023 · Aethlon Announces Reverse Stock Split · Persbericht

30 augustus 2023 · Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference · Persbericht

10 augustus 2023 · Aethlon Medical Announces Fiscal First Quarter Financial Results and Provides Corporate Update · Persbericht

3 augustus 2023 · Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 10, 2023 · Persbericht

Mijn selecties